NCT02473276View on ClinicalTrials.gov

2 Dose Neuraxial Morphine for Prevention of PDPH

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Postdural Puncture Headache
Interventions
DRUG

Morphine

preservative free morphine given either via an epidural or intrathecal catheter

DRUG

Sterile normal saline

sterile normal saline, given either via an epidural or intrathecal catheter

Trial Locations (4)

10021

Weill Cornell Medical Center, New York

10032

New York Presbyterian Hospital, New York

10467

Montefiore Hospital, New York

07103

Rutgers Health University Hospital, Newark

All Listed Sponsors
collaborator

Montefiore Medical Center

OTHER

collaborator

Rutgers University

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

lead

Columbia University

OTHER

NCT02473276 - 2 Dose Neuraxial Morphine for Prevention of PDPH | Biotech Hunter | Biotech Hunter